LEANDREA TZITZICAS: Open Payments
NPI 1174070536 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,979 in 175 payments from 27 companies in 2025. Trend: 2023 $2,166 · 2024 $2,870 · 2025 $2,979
Food & beverage: $2,979
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 43 | $466 |
| PFIZER INC. | 20 | $248 |
| ARGENX US, INC. | 8 | $226 |
| Janssen Biotech, Inc. | 9 | $218 |
| ABBVIE INC. | 16 | $211 |
| Alexion Pharmaceuticals, Inc. | 9 | $181 |
| Neurocrine BioSciences, Inc. | 5 | $148 |
| Merz Pharmaceuticals, LLC | 6 | $135 |
| SK Life Science, Inc. | 6 | $133 |
| TG Therapeutics, Inc. | 6 | $131 |
Products named: Briviact, ULTOMIRIS, NURTEC ODT, INGREZZA, Xeomin, BRIUMVI, VYVGART HYTRULO, UBRELVY.
Industry payments across CO — which companies pay providers there.
